Recommended Treatment for Asthma
Inhaled corticosteroids (ICS) are the most effective first-line controller medication for persistent asthma and should be the foundation of treatment, with short-acting beta-agonists (SABA) reserved for intermittent symptoms or rescue therapy. 1, 2
Stepwise Treatment Algorithm
Step 1: Intermittent Asthma
- Use as-needed SABA only (no daily controller medication required) 3, 2
- If SABA is needed more than twice weekly for symptom relief (excluding exercise-induced symptoms), this indicates inadequate control and necessitates stepping up to controller therapy 1, 2
Step 2: Mild Persistent Asthma
- Initiate low-dose ICS (200-250 mcg fluticasone propionate equivalent daily) as the preferred treatment 3, 2
- This dose achieves 80-90% of maximum therapeutic benefit in adult asthma 4
- Alternative options (though not preferred): leukotriene receptor antagonists, which offer advantages of ease of use and high compliance rates 3
Step 3: Moderate Persistent Asthma
- Add long-acting beta-agonist (LABA) to low-dose ICS as the preferred combination therapy for patients 12 years and older 1, 3, 2
- The ICS/LABA combination provides superior asthma control compared to doubling or quadrupling ICS dose alone 5, 6
- Critical warning: Never use LABA as monotherapy - this increases risk of asthma-related events including deaths 3, 7
- Alternative: Consider increasing ICS dose to medium range (up to 500 mcg fluticasone equivalent) if LABA cannot be used 1
Step 4: Severe Persistent Asthma
- High-dose ICS plus LABA combination 2
- Maximum recommended dose: 500 mcg fluticasone propionate twice daily with salmeterol 50 mcg 8
Acute Exacerbation Management
For moderate to severe exacerbations, prescribe oral prednisolone 30-40 mg daily until lung function returns to baseline (typically 7 days, may extend to 21 days) 1, 2
Key points for acute management:
- Oral steroids are equally effective as intravenous administration 1
- Short courses (up to 2 weeks) do not require tapering 1
- Deliver SABA via nebulizer or large-volume spacer depending on severity 1
- Indications for rescue steroids include: worsening symptoms with peak flow <60% of best, sleep disturbance, or diminishing response to bronchodilators 1
Delivery Device Selection
Start with metered-dose inhaler (MDI); if technique is inadequate, add a large-volume spacer 1
- MDI with spacer provides comparable bronchodilation to nebulizer treatment when 6-10 puffs are administered sequentially 1
- Common pitfall: Two puffs from MDI are NOT equivalent to one nebulizer treatment 1
- If MDI plus spacer is too bulky for daytime use, switch to the most affordable powder or automatic aerosol inhaler the patient can use correctly 1
Monitoring and Adjustment
Assess control at every visit and adjust therapy accordingly 3:
- Before stepping up therapy, verify: medication adherence, proper inhaler technique, and environmental trigger control 3
- Step down therapy only after asthma is well-controlled for at least 3 months 3
- Warning signs requiring intensification: SABA use >2 days/week or >2 nights/month 1, 2
Special Considerations
Pediatric Patients (Ages 4-11 Years)
Comorbidity Management
- Treat allergic rhinitis, sinusitis, and gastroesophageal reflux as these worsen asthma control 2
- Provide annual influenza vaccination for all patients with persistent asthma 2
Patient Education Requirements
- Teach proper inhaler technique and verify at each visit 1, 3
- Provide written action plan with color-coded zones (green/yellow/red) for self-management 1
- Advise mouth rinsing after ICS use to prevent oral candidiasis 8
Common Pitfalls to Avoid
- Using LABA monotherapy - always combine with ICS 3, 7
- Inadequate ICS dosing - starting at 200-250 mcg fluticasone equivalent achieves near-maximal benefit 4
- Failing to step up when SABA overuse occurs - this indicates poor control 1, 2
- Assuming 2 MDI puffs equal nebulizer treatment - use 6-10 puffs for equivalent effect 1
- Not checking inhaler technique before escalating therapy - poor technique is a common cause of treatment failure 3